Last reviewed · How we verify

Laif® 900, BAY98-7108 — Competitive Intelligence Brief

Laif® 900, BAY98-7108 (Laif® 900, BAY98-7108) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal antidepressant / Phytopharmaceutical. Area: Psychiatry / Mental Health.

phase 3 Herbal antidepressant / Phytopharmaceutical Serotonin transporter (SERT), norepinephrine transporter (NET), dopamine transporter (DAT) Psychiatry / Mental Health Small molecule Live · refreshed every 30 min

Target snapshot

Laif® 900, BAY98-7108 (Laif® 900, BAY98-7108) — Bayer. Laif 900 is a standardized St. John's Wort extract that modulates serotonin and other neurotransmitter systems to improve mood in depression.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Laif® 900, BAY98-7108 TARGET Laif® 900, BAY98-7108 Bayer phase 3 Herbal antidepressant / Phytopharmaceutical Serotonin transporter (SERT), norepinephrine transporter (NET), dopamine transporter (DAT)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal antidepressant / Phytopharmaceutical class)

  1. Bayer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Laif® 900, BAY98-7108 — Competitive Intelligence Brief. https://druglandscape.com/ci/laif-900-bay98-7108. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: